CNCE Concert Pharmaceuticals, Inc.

16.08
+0  (0%)
Previous Close 16.08
Open 16.24
Price To book 4.19
Market Cap 359.03M
Shares 22,328,000
Volume 415,990
Short Ratio 1.09
Av. Daily Volume 427,492

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Noted April 5, 2017 delay in initiation of Phase 2a trial. Initiation due in 2017 with data due 1Q 2018.
CTP-543
Alopecia areata
Phase 2 trial initiation announced December 21, 2016. Data due by end of 2017.
CTP-656
Cystic fibrosis
Phase 3 initiated December 2015. Trial to be completed 3Q 2018
AVP-786
Agitation in patients with Alzheimer's disease
Phase 3 planned. Needs partner
CTP-499
Diabetic Kidney Disease

Latest News

  1. Concert Pharmaceuticals to Report First Quarter 2017 Financial Results on May 2, 2017, and Present at Upcoming Investor Conferences
  2. ETFs with exposure to Concert Pharmaceuticals, Inc. : April 7, 2017
  3. Why Concert Pharmaceuticals Is Music to Investors' Ears
  4. Concert rebuffed $250M buyout offer from Vertex before CF drug deal
  5. Will Concert Pharmaceuticals (CNCE) Continue to Surge Higher?
  6. Moving Average Crossover Alert: Concert Pharmaceuticals (CNCE)
  7. After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead
  8. 3 Biotech Stocks to Buy in March
  9. Concert Pharmaceuticals, Inc. :CNCE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017
  10. RDInvesting.com: Coverage Initiated on Concert Pharmaceuticals, Price Surges
  11. Concert Pharmaceuticals, Inc.: Strong price momentum but will it sustain?
  12. Harry Boxer’s six biotechnology stocks to watch
  13. Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M
  14. Concert Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : CNCE-US : March 7, 2017
  15. Monday’s Top Health Care Stocks Screaming Higher
  16. Edited Transcript of CNCE earnings conference call or presentation 6-Mar-17 1:30pm GMT
  17. $160M deal with Concert helps Vertex maintain dominance in cystic fibrosis
  18. Why Concert Pharmaceuticals Stock Is Soaring Today
  19. What You Must Know About Cystic Fibrosis Drug CTP-656
  20. Concert Pharma shares rally 34% on news Vertex to pay up to $250 million for cystic fibrosis drug